Jianping Guo

发表

Sub category : Coronary Heart Disease Angina and Future Cardiovascular Events in Stable Patients with Coronary Artery Disease : Insights from the REACH registry

Deepak L. Bhatt, K. Eagle, E. Ohman, 2016 .

Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36

Ravi B. Patel, D. Morrow, B. Scirica, 2017, European heart journal. Acute cardiovascular care.

Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial

Dylan L. Steen, M. Sabatine, E. Braunwald, 2018, JAMA cardiology.

Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

C. Held, C. Cannon, E. Michelson, 2016, Circulation. Arrhythmia and electrophysiology.

Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial).

R. Califf, R. Giugliano, E. Braunwald, 2014, The American journal of cardiology.

Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy.

J. Mega, M. Sabatine, A. Kastrati, 2011, American heart journal.

De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry.

D. Morrow, S. Sinha, C. Fordyce, 2021, Journal of cardiac failure.

Cognition After Lowering LDL-Cholesterol With Evolocumab.

Hong Wang, A. Keech, R. Giugliano, 2020, Journal of the American College of Cardiology.

Management and Outcomes of Cardiogenic Shock in Cardiac ICUs With Versus Without Shock Teams.

D. Morrow, S. Sinha, D. Berg, 2021, Journal of the American College of Cardiology.

Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes.

D. Morrow, S. Sinha, D. Berg, 2020, JAMA cardiology.

Plasma Omega‐3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN‐TIMI 36

D. Mozaffarian, M. Sabatine, D. Morrow, 2021, Journal of the American Heart Association.

Risk Factors and Outcomes of Acute Myocardial Infarction in a Cohort of Antiphospholipid Syndrome

Chun Xing Li, H. Ye, Yawei Zhao, 2022, Frontiers in Cardiovascular Medicine.

Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials Network

D. Morrow, S. Sinha, D. Berg, 2022, Journal of Cardiac Failure.

Characteristics, therapies, and outcomes of In-Hospital vs Out-of-Hospital cardiac arrest in patients presenting to cardiac intensive care units: From the critical care Cardiology trials network (CCCTN).

C. Granger, D. Morrow, L. Newby, 2022, Resuscitation.

NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.

Deepak L. Bhatt, K. Eagle, C. Cannon, 2014, The American journal of medicine.

The effect of fasting status on lipids, lipoproteins, and inflammatory biomarkers assessed after hospitalization for an acute coronary syndrome: Insights from PROVE IT–TIMI 22

Dylan L. Steen, C. Cannon, N. Khan, 2018, Clinical cardiology.

Point‐of‐Care Platelet Function Testing Predicts Bleeding in Patients Exposed to Clopidogrel Undergoing Coronary Artery Bypass Grafting: Verify Pre‐Op TIMI 45—A Pilot Study

C. Cannon, S. Aranki, A. Maree, 2015, Clinical cardiology.

Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49).

C. Gibson, G. Stouffer, K. Bainey, 2019, The American journal of cardiology.

No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab

Laura E. Korthauer, D. Atar, A. Keech, 2022, PloS one.

Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials

Deepak L. Bhatt, E. Antman, R. Giugliano, 2021, Circulation.

Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary Syndromes.

E. Antman, R. Giugliano, M. Sabatine, 2019, Journal of the American College of Cardiology.

Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial

J. Mega, D. Morrow, C. Gibson, 2014, Journal of Thrombosis and Thrombolysis.

Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality: Insights From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel—Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38)

E. Antman, R. Giugliano, E. Braunwald, 2011, Circulation.

Permanent Drug Discontinuation , and Study Retention in Clinical Trials Insights From the TIMI trials

Deepak L. Bhatt, E. Antman, R. Giugliano, 2021 .

Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis

Marc P. Bonaca, M. Pfeffer, R. Giugliano, 2022, European heart journal.

Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry

Deepak L. Bhatt, K. Eagle, E. Ohman, 2016, Journal of the American Heart Association.

Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials

Deepak L. Bhatt, E. Antman, J. Mega, 2018, European heart journal.

Authors' Reply

C. Cannon, S. Aranki, A. Maree, 2013, British Journal of Psychiatry.

Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Angiography.

R. Giugliano, M. Sabatine, L. Newby, 2020, Journal of the American College of Cardiology.

The Incidence of Kidney Injury for Patients Treated With a High‐Potency Versus Moderate‐Potency Statin Regimen After an Acute Coronary Syndrome

J. Mega, M. Sabatine, J. Rouleau, 2014, Journal of the American Heart Association.

Validation of the Seattle angina questionnaire in women with ischemic heart disease

J. Spertus, D. Morrow, P. Chan, 2018, American heart journal.

Presentation and Outcomes of Patients With Preoperative Critical Illness Undergoing Cardiac Surgery

D. Morrow, C. Fordyce, D. Berg, 2023, JACC. Advances.

Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry

Deepak L. Bhatt, K. Eagle, E. Ohman, 2016, Journal of the American Heart Association.

MODELLING ECONOMIC POLICY RESPONSES WITH AN APPLICATION TO THE G 3

Deepak L. Bhatt, R. Diaz, A. Keech, 2006 .

International Policy Coordination

Deepak L. Bhatt, R. Diaz, A. Keech, 2006 .

Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial

Dylan L. Steen, M. Sabatine, E. Braunwald, 2018, JAMA cardiology.

Interhospital Variation in Admissions Managed With Critical Care Therapies or Invasive Hemodynamic Monitoring in Tertiary Cardiac Intensive Care Units: An Analysis From the Critical Care Cardiology Trials Network Registry

Rajnish K. Prasad, E. Bohula, M. Kontos, 2024, Circulation. Cardiovascular quality and outcomes.